1988
DOI: 10.1016/0887-2333(88)90008-2
|View full text |Cite
|
Sign up to set email alerts
|

Use of the whole-embryo culture system in drug safety assessment?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

1988
1988
2012
2012

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 15 publications
0
8
0
Order By: Relevance
“…There is a high rate of concurrence between in vivo and in vitro embryotoxicity of several compounds [91]. In the case of non-correlation, an additional pharmacokinetic analysis comparing the embryo concentration of the test substance in vivo and in vitro may explain the lack of concurrence.…”
Section: Pharmacokinetic Aspects In Wecmentioning
confidence: 99%
“…There is a high rate of concurrence between in vivo and in vitro embryotoxicity of several compounds [91]. In the case of non-correlation, an additional pharmacokinetic analysis comparing the embryo concentration of the test substance in vivo and in vitro may explain the lack of concurrence.…”
Section: Pharmacokinetic Aspects In Wecmentioning
confidence: 99%
“…When the artificial in vitro exposure conditions are combined with the relatively brief period during which embryos can be cultured and the resultant abbreviated time for regulation, the likelihood of observing developmental delays in cultured embryos is enhanced. In fact, several review papers on whole embryo culture [Bechter and Schön, 1988;Tesh, 1988;New, 1990;Guest et al, 1994] have noted that, even among embryos cultured under control conditions, NTDs are regularly observed at incidence rates of 2-7%, although rates can be as low as 0% and as high as 10+%. These rates greatly exceed the incidences of malformations seen at term in rodents (Table II) and in humans (Table I).…”
Section: Embryo Culture Studiesmentioning
confidence: 99%
“…The clinical significance of a specific drug-drug interaction depends on the degree of accumulation of the substrate and the therapeutic window of the substrate (Bachmann, Lewis, 2005). The combination of theophylline and ketotifen is often used in respiratory tract infections and some have suggested that the combination is effective (Benjamin et al, 1994), while others have postulated that the combination may be embryotoxic, leading to growth retardation and morphological abnormalities (Bechter, Schön, 1988). The major goal of the present study was to elucidate the possible importance of drug-drug interactions (DDIs) as a contributing factor towards drug safety and finally to observe and determine the stability of the complexes which could be formed by the interaction of ketotifen fumarate with anhydrous theophylline in aqueous media at variable pH.…”
Section: Introductionmentioning
confidence: 99%